Evidence map›Paper›PMID 35460649›Full record

ArticleThe Lancet. Infectious diseases2022

Is triple artemisinin-based combination therapy necessary for uncomplicated malaria?

Chengchao Xu, Yin Kwan Wong, Fu Long Liao, Tingliang Jiang, Jigang Wang, Youyou Tu

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in The Lancet. Infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Chengchao XuShenzhen People's Hospital, Shenzhen, China; Artemisinin Research Centre and the Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100070, China.
Yin Kwan WongShenzhen People's Hospital, Shenzhen, China.
Fu Long LiaoArtemisinin Research Centre and the Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100070, China.
Tingliang JiangArtemisinin Research Centre and the Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100070, China.
Jigang WangShenzhen People's Hospital, Shenzhen, China; Artemisinin Research Centre and the Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100070, China. Electronic address: jgwang@icmm.ac.cn.
Youyou TuArtemisinin Research Centre and the Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100070, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AntimalarialsArtemisininsMalariaMalaria, FalciparumDrug CombinationsDrug Therapy, CombinationHumansPlasmodium falciparumAntimalarialsartemisininArtemisininsDrug Combinations

Identifiers

PMID35460649

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.